Skip to main content

Closed

LXEO: Lexeo Therapeutics, Inc. Common Stock Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-40.9%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage-534.3×

Current ratio14.16×

Lexeo Therapeutics, Inc. Common Stock

LXEONASDAQ Global Market·USD·Closed

Lexeo Therapeutics, Inc. Common Stock

LXEONASDAQ·USD·Closed

$4.13

−5.06%

$4.13

−$0.22 (5.06%)

52W Range

1thpctl

Volume

0.80×avg

Mkt Cap

324.29MUSD

P/E

-2.8TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.80×avg

Market Cap

324.29MUSD

P/E Ratio

-2.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings